Cargando…
Tumor-related cytokine release syndrome in a treatment-naïve patient with lung adenocarcinoma: A case report
BACKGROUND: Cytokine release syndrome (CRS) is defined as systemic inflammation that usually occurs following chimeric antigen receptor T-cell therapy administration; however, it has not been reported in patients with untreated non-small cell lung cancer to date. CASE SUMMARY: A 44-year-old nonsmoki...
Autores principales: | Deng, Peng-Bo, Jiang, Juan, Hu, Cheng-Ping, Cao, Li-Ming, Li, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855264/ https://www.ncbi.nlm.nih.gov/pubmed/35211595 http://dx.doi.org/10.12998/wjcc.v10.i5.1580 |
Ejemplares similares
-
Pembrolizumab-induced cytokine release syndrome in a patient with metastatic lung adenocarcinoma: a case report
por: Sackstein, Paul, et al.
Publicado: (2021) -
Cytokine release syndrome
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2018) -
Interferon with Dogma in Cytokine Release Syndrome and Acute Lung Injury
por: Denstaedt, Scott J., et al.
Publicado: (2022) -
Rituximab and Cytokine Release Syndrome
por: Kulkarni, Hrishikesh S., et al.
Publicado: (2012) -
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome
por: Arcangeli, Silvia, et al.
Publicado: (2022)